Abstract
More than 1 million individuals in the United States are HIV positive, with greater than 40,000 new patients being diagnosed per year. With the advent of highly active antiretroviral therapy (HAART), HIV-infected patients in the United States are living longer. HIV-infected patients receiving HAART now more commonly have noninfectious and nonopportunistic complications of their disease. This review article will discuss the assessment and treatment of HIV-positive patients in the era of HAART, with an emphasis on the noninfectious and changing infectious complications that require emergency care.
MeSH terms
-
AIDS-Related Opportunistic Infections / chemically induced*
-
Anti-Retroviral Agents / adverse effects*
-
Antiretroviral Therapy, Highly Active / adverse effects*
-
Cardiovascular Diseases / chemically induced*
-
Cardiovascular Diseases / complications
-
Drug Interactions
-
Emergency Service, Hospital / statistics & numerical data*
-
Gastrointestinal Diseases / chemically induced*
-
Gastrointestinal Diseases / complications
-
Gastrointestinal Diseases / physiopathology
-
HIV Infections* / complications
-
HIV Infections* / drug therapy
-
HIV Infections* / psychology
-
Humans
-
Mental Disorders / etiology*
-
Musculoskeletal Diseases / chemically induced*
-
Musculoskeletal Diseases / etiology
-
Risk Factors
-
Skin Diseases / chemically induced*
-
Skin Diseases / complications